Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.

Ítems similars

• Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
  per: Hardy, C. C., et al.
  Publicat: (1986)
• Identification of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the circulation during infusions of bradykinin and prostaglandin E2 in man.
  per: Barrow, S. E., et al.
  Publicat: (1987)
• The effect of sulindac on growth differentiation factor 15 and 13,14-dihydro-15-keto prostaglandin A(2 )in nipple aspirate fluid
  per: Thompson, PA, et al.
  Publicat: (2009)
• Use of urinary 13,14, dihydro-15-keto-prostaglandin F(2α) (PGFM) concentrations to diagnose pregnancy and predict parturition in the giant panda (Ailuropoda melanolecua)
  per: Roberts, Beth M., et al.
  Publicat: (2018)
• Plasma Levels of 15-Keto-13,14-Dihydroprosta-Glandin F(2α) in Primiparous Lactating Sows
  per: Kunavongkrit, A., et al.
  Publicat: (1984)